From: Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials
Adverse Events
Studies Reporting (n)
ACEI/ARB Group (n/n)
Control Group (n/n)
RR (95% CI)
P Value
Hyperkalemia
5
33/604
24/605
1.29 (0.76,2.17)
0.34
Hypotension
54/604
54/605
1.03 (0.73,1.45)
0.87
Cough
2
3/75
0/77
2.63 (0.00,39,507.62)
0.84